- Home
- BDTX vs SOPH Comparison
BDTX vs SOPH Comparison
Compare BDTX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDTX | SOPH |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 367.7M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BDTX | SOPH |
|---|---|---|
| Price | $2.13 | $4.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $10.20 | $7.00 |
| AVG Volume (30 Days) | ★ 581.5K | 101.2K |
| Earning Date | 03-16-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 130.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | $5.62 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $2.58 |
| 52 Week High | $4.94 | $5.70 |
Technical Indicators
Market Signals| Indicator | BDTX | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 43.81 | 50.05 |
| Support Level | $1.93 | $4.54 |
| Resistance Level | $2.30 | $4.86 |
| Average True Range (ATR) | 0.11 | 0.27 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 36.54 | 43.75 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.